Physician

Christopher Brooks Morse, M.D.

According to 2025 Medicare claims, Christopher Morse, M.D. (NPI: 1689940017) practices gynecologist/oncologist in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is ALLEGHENY CLINIC (NPI: 1518393164; TIN: 251838458) and primary practice location at 15224-1722. Morse is affiliated with the Physician Partners of Western PA LLC (ACO ID: A3547), participating under the MSSP model.

Morse's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 125 traditional Medicare patients, billed 352 HCPCS/CPT codes, and received $53,781 in Medicare payments. The top billing code was 58571 (Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less). Part D data shows 108 prescription claims across 28 beneficiaries totaling $154,920 in drug costs, led by Prochlorperazine Maleate (Prochlorperazine Maleate). Open Payments data shows 2 records totaling $261. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,172 and ending at $154,920. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$27K$54K2020 Medicare payment: $6,468 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $40,733 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $47,134 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $39,607 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $53,781 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20203044$6,468
202178223$40,733
202296269$47,134
2023105286$39,607
2024125352$53,781

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$77K$155K2015 Drug cost: $5,172 (USD; Tot_Drug_Cst)2016 Drug cost: $1,109 (USD; Tot_Drug_Cst)2018 Drug cost: $2,267 (USD; Tot_Drug_Cst)2019 Drug cost: $4,055 (USD; Tot_Drug_Cst)2020 Drug cost: $3,730 (USD; Tot_Drug_Cst)2021 Drug cost: $698 (USD; Tot_Drug_Cst)2022 Drug cost: $451 (USD; Tot_Drug_Cst)2023 Drug cost: $16,819 (USD; Tot_Drug_Cst)2024 Drug cost: $154,920 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154083$5,172
20161531$1,109
2017N/RN/RN/R
20182359$2,267
20193368$4,055
20201748$3,730
20212638$698
20221222$451
20233487$16,819
202428108$154,920

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
58571Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less1313$706
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3636$171
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2580$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6792$63
99231Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes2437$38

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prochlorperazine MaleateProchlorperazine Maleate12170$257
DexamethasoneDexamethasone2060$102

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$261PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Brooks Morse, M.D.?

Tedicare shows public-source Medicare data for Christopher Brooks Morse, M.D. (NPI 1689940017), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Brooks Morse, M.D. have ACO affiliation data?

Christopher Brooks Morse, M.D. is shown with ACO affiliation data for Physician Partners of Western PA LLC (MSSP, ACO ID A3547).

What billing organization is linked to Christopher Brooks Morse, M.D.?

Christopher Brooks Morse, M.D. is linked to ALLEGHENY CLINIC (billing NPI 1518393164) in the available physician profile data.

Does Christopher Brooks Morse, M.D. have Open Payments data?

Christopher Brooks Morse, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.